indenopyrazole/quinazoline CDK inhibitors (BMS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameindenopyrazole/quinazoline CDK inhibitors (BMS)
Drug Alias Nameindenopyrazole/quinazoline CDK inhibitors (DuPont)A-3915
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDupont Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDupont PharmaBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A